Effect of dexfenfluramine on gastric emptying of a mixed solid-liquid meal in obese subjects.
Recent studies suggest that dexfenfluramine (D-fenfluramine), because of its pure serotonergic effect, may be a more potent anti-obesity agent, associated with fewer side-effects than the racemate DL-fenfluramine. The effect of dexfenfluramine on gastric emptying of a mixed solid and liquid meal was assessed with a double-isotope scintigraphic technique in eleven obese patients. Each subject took a placebo capsule on the morning and evening of the day before, and on the morning of the first gastric emptying measurement. Dexfenfluramine was then taken at a dose of 15 mg twice daily and gastric emptying measurements were performed at 5 and at 29 d after the initiation of active treatment. Dexfenfluramine significantly slowed gastric emptying of the solid meal at both 5 and 29 d when compared with the placebo (P less than 0.05) and also delayed emptying of solid food from the proximal stomach (P less than 0.01), but no significant effect on liquid emptying was observed. No significant side-effects were reported and there was a marginal weight loss (P less than 0.005) during treatment. We conclude that inhibition of gastric emptying may contribute to the efficacy of dexfenfluramine in the treatment of obesity.
Horowitz
M
M
Department of Medicine, Royal Adelaide Hospital, North Terrace, Australia.
Maddox
A
A
Wishart
J
J
Vernon-Roberts
J
J
Chatterton
B
B
Shearman
D
D
D000293:Adolescent; D000328:Adult; D001835:Body Weight / Q000187:drug effects; D005260:Female; D005277:Fenfluramine / Q000627:therapeutic use*; D005502:Food; D005746:Gastric Emptying / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000188:drug therapy*; D013237:Stereoisomerism
D005277:Fenfluramine